Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma. | BMC Cancer | 2021 | 34372798 | PubTator, text mining | PubMed |
Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle-Apoptosis and PI3K Signalling Pathways. | Front Pharmacol | 2021 | 34366863 | PubTator, text mining | PubMed |
| Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. | Cancers (Basel) | 2021 | 34359745 | PubTator, text mining | PubMed |
| Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies. | Cancers (Basel) | 2021 | 34359720 | PubTator, text mining | PubMed |
| Targeting RB1 Loss in Cancers. | Cancers (Basel) | 2021 | 34359636 | PubTator, text mining | PubMed |
| A novel fusion circular RNA F-circBA1 derived from the BCR-ABL fusion gene displayed an oncogenic role in chronic myeloid leukemia cells. | Bioengineered | 2021 | 34346842 | PubTator, text mining | PubMed |
| The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC). | J Egypt Natl Canc Inst | 2021 | 34337682 | PubTator, text mining | PubMed |
| Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits. | Oxid Med Cell Longev | 2021 | 34336089 | PubTator, text mining | PubMed |
| A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer. | BMC Cancer | 2021 | 34315420 | PubTator, text mining | PubMed |
| The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer. | Cancers (Basel) | 2021 | 34298684 | PubTator, text mining | PubMed |
| AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. | Int J Gen Med | 2021 | 34285555 | PubTator, text mining | PubMed |
| Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B. | Bioorg Med Chem Lett | 2021 | 34273487 | PubTator, text mining | PubMed |
| Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy. | Commun Biol | 2021 | 34267311 | PubTator, text mining | PubMed |
| An Investigation of the Antigastric Cancer Effect in Tumor Microenvironment of Radix Rhei Et Rhizome: A Network Pharmacology Study. | Evid Based Complement Alternat Med | 2021 | 34257692 | PubTator, text mining | PubMed |
| Epigenetics in Kawasaki Disease. | Front Pediatr | 2021 | 34249810 | PubTator, text mining | PubMed |
| MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. | J Ovarian Res | 2021 | 34238324 | PubTator, text mining | PubMed |
| Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease. | Brain Pathol | 2021 | 34218486 | PubTator, text mining | PubMed |
| Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins. | Molecules | 2021 | 34207840 | PubTator, text mining | PubMed |
| p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies. | Cancers (Basel) | 2021 | 34207603 | PubTator, text mining | PubMed |
| FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer. | Cancers (Basel) | 2021 | 34205406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=22